Literature DB >> 20405879

Synthesis of (-)-(S,S)-clemastine by invertive N --> C aryl migration in a lithiated carbamate.

Anne M Fournier1, Robert A Brown, William Farnaby, Hideki Miyatake-Ondozabal, Jonathan Clayden.   

Abstract

The first enantioselective synthesis of the antihistamine agent clemastine, as its (S,S)-stereoisomer, has been achieved by ether formation between a proline-derived chloroethylpyrrolidine and an enantiomerically enriched tertiary alcohol. The tertiary alcohol was formed from the carbamate derivative of alpha-methyl-p-chlorobenzyl alcohol by invertive aryl migration on lithiation. The (S,S)-stereochemistry of the product confirms the invertive nature of the rearrangement.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20405879     DOI: 10.1021/ol100627c

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  4 in total

1.  Ru-Catalyzed Asymmetric Addition of Arylboronic Acids to Aliphatic Aldehydes via P-Chiral Monophosphorous Ligands.

Authors:  Rui Miao; Yanping Xia; Yifei Wei; Lu Ouyang; Renshi Luo
Journal:  Molecules       Date:  2022-06-17       Impact factor: 4.927

2.  C(sp3)-Arylation by Conformationally Accelerated Intramolecular Nucleophilic Aromatic Substitution (SNAr).

Authors:  Steven M Wales; Rakesh K Saunthwal; Jonathan Clayden
Journal:  Acc Chem Res       Date:  2022-05-27       Impact factor: 24.466

3.  Asymmetric addition of Grignard reagents to ketones: culmination of the ligand-mediated methodology allows modular construction of chiral tertiary alcohols.

Authors:  Claudio Monasterolo; Ryan O'Gara; Saranna E Kavanagh; Sadbh E Byrne; Bartosz Bieszczad; Orla Murray; Michael Wiesinger; Rebecca A Lynch; Kirill Nikitin; Declan G Gilheany
Journal:  Chem Sci       Date:  2022-04-20       Impact factor: 9.969

4.  Asymmetric synthesis of tertiary thiols and thioethers.

Authors:  Jonathan Clayden; Paul Maclellan
Journal:  Beilstein J Org Chem       Date:  2011-05-10       Impact factor: 2.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.